Monday, March 27, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home CBRNE

Ansell Introduces New CBRN Protective Suit in U.S.

by Global Biodefense Staff
November 19, 2014
Ansell CBRN Protective Suits

Ansell, a global leader in protection solutions, recently announced the U.S. launch of Trellchem ACT, a new protective solution for law enforcement responders dealing with consequences of Chemical, Biological, Radiological and Nuclear (CBRN) incidents.

Duties of the law enforcement community have become much more complex and challenging with the realization of new kind of threats, as introduced by the 9/11 attacks in 2001. Today, law enforcement teams are expected to take active roles in the response to terrorism and potential terrorist threats.

The personal protective equipment (PPE) used by these responders consequently needs to be adapted to fulfill the special demands and requirements set forth by close contact with various CBRN substances, while at the same time not limiting the ability for adequate response. To be truly effective, PPE equipment intended for safekeeping of law enforcement personnel must consider and put focus on both garment material, as well as garment design and comfort.

Trellchem ACT is developed with a system-level perspective to offer law enforcement and other CBRN terrorism response teams the best possible protection and comfort when engaging in incidents involving high levels of CBRN hazards where concentrations are recognized to be at IDLH levels (lethal).

Highlighted features of the suit include:

  • Strong, durable and lightweight technical fabric
  • Fluoro-based barrier film
  • High level wearer comfort
  • Minimum noise level from being active in the suit
  • Elasticated waist for good fit
  • Shoulder paddings to ease discomfort from the SCBA load
  • External neck strap fitted for optimal comfort of the hood
  • 3D shaped mask seal of hood for maximum safety
  • Gloves are offered with permanent or ring attachment options

“With TRELLCHEM ACT, Ansell is expanding its protective clothing offering in a new and exciting direction” says François le Jeune, Senior Vice President Business Development and Transformational Initiatives at Ansell. “By combining our unique knowledge of protective clothing solutions with user comfort requirements, we are helping to protect these brave responders in their most challenging missions.”

The ACT ensemble fulfils NFPA 1994 (class 2), 2012 edition and consists of garment, gloves, and footwear tested and certified as one protective system, with a manufacturer specified CBRN respiratory protective device. For the Trellchem ACT ensemble, SCBA units by both Scott and MSA has been certified and approved for use, along with Onguard Hazmax® boots as protective footwear.

Source: Ansell press release, adapted. Trellchem® is a registered trademark owned by Trelleborg AB. Hazmax® is a registered trademark of ONGUARD Industries, L.L.C.

Tags: CBRN EquipmentMobile Response

Related Posts

small glass vials on an assembly line await filling of vaccine solution
Industry News

Sabin Vaccine Institute to Advance Ebola Sudan and Marburg Vaccines with New BARDA Funding

January 12, 2023
two soldiers are in head-to-toe hazmat suits with respirator masks while tending to a mannikin on a stretcher
CBRNE

Protection from Biothreats: DOD to Modernize Medical Countermeasures Development

January 10, 2023
DoD Awards ENA Respiratory $4.38M for Broad-Spectrum Antiviral Development
Industry News

DoD Awards ENA Respiratory $4.38M for Broad-Spectrum Antiviral Development

January 10, 2023
Killing Anthrax More Quickly with Hot Air Decontamination
CBRNE

Killing Anthrax More Quickly with Hot Air Decontamination

January 4, 2023
Load More

Latest News

Biodefense Headlines – 26 March 2023

March 26, 2023
Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC